The factor V G1691A, factor V H1299R, prothrombin G20210A polymorphisms in children with family history of premature coronary artery disease

Coron Artery Dis. 2009 Nov;20(7):435-9. doi: 10.1097/MCA.0b013e32832bdb8c.

Abstract

Atherosclerosis, the major cause of coronary artery disease (CAD), has a very long asymptomatic development phase, which begins in childhood. In this study, we describe the factor V G1691A, factor V H1299R and prothrombin G20210A gene polymorphisms in children with a family history of premature CAD. Evidence of these polymorphisms in these children may predict the probability of having atherosclerosis in the future. Our study included a total of 140 children, 72 males and 68 females between the ages of 4.9 and 15.7 years. Among these children, 73 had a parental history of premature CAD and the remaining 67 belonged to our control group. The participants were screened for the mutations factor V G1691A, factor V H1299R and prothrombin G20210A by polymerase chain reaction amplified DNA products with specific oligonucleotide probes. Our results suggested that frequencies of the mutated allele of factor V G1691A and prothrombin G20210A are higher in children with a parental history of premature CAD. In conclusion, factor V G1691A and prothrombin G20210A polymorphisms which were detected in higher frequencies in children with a parental history of premature CAD may indicate a risk for developing atherosclerosis and might be useful in screening for CAD in children; however, large population-based research is necessary to investigate further genetic risk assessment for CAD.

MeSH terms

  • Adolescent
  • Age of Onset
  • Atherosclerosis / blood
  • Atherosclerosis / epidemiology
  • Atherosclerosis / genetics*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / genetics*
  • Factor V / genetics*
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Mutation
  • Pedigree
  • Polymorphism, Genetic*
  • Prothrombin / genetics*
  • Risk Assessment
  • Risk Factors

Substances

  • Factor V
  • Prothrombin